Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
The DOI matches its Crossref record; 614 of the 626 references it cites were found in a registry or an index.
Abstract
The 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase (3beta-HSD) isoenzymes are responsible for the oxidation and isomerization of Delta(5)-3beta-hydroxysteroid precursors into Delta(4)-ketosteroids, thus catalyzing an essential step in the formation of all classes of active steroid hormones. In humans, expression of the type I isoenzyme accounts for the 3beta-HSD activity found in placenta and peripheral tissues, whereas the type II 3beta-HSD isoenzyme is predominantly expressed in the adrenal gland, ovary, and testis, and its deficiency is responsible for a rare form of congenital adrenal hyperplasia. Phylogeny analyses of the 3beta-HSD gene family strongly suggest that the need for different 3beta-HSD genes occurred very late in mammals, with subsequent evolution in a similar manner in other lineages. Therefore, to a large extent, the 3beta-HSD gene family should have evolved to facilitate differential patterns of tissue- and cell-specific expression and regulation involving multiple signal transduction pathways, which are activated by several growth factors, steroids, and cytokines. Recent studies indicate that HSD3B2 gene regulation involves the orphan nuclear receptors steroidogenic factor-1 and dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1 (DAX-1). Other findings suggest a potential regulatory role for STAT5 and STAT6 in transcriptional activation of HSD3B2 promoter. It was shown that epidermal growth factor (EGF) requires intact STAT5; on the other hand IL-4 induces HSD3B1 gene expression, along with IL-13, through STAT 6 activation. However, evidence suggests that multiple signal transduction pathways are involved in IL-4 mediated HSD3B1 gene expression. Indeed, a better understanding of the transcriptional factors responsible for the fine control of 3beta-HSD gene expression may provide insight into mechanisms involved in the functional cooperation between STATs and nuclear receptors as well as their potential interaction with other signaling transduction pathways such as GATA proteins. Finally, the elucidation of the molecular basis of 3beta-HSD deficiency has highlighted the fact that mutations in the HSD3B2 gene can result in a wide spectrum of molecular repercussions, which are associated with the different phenotypic manifestations of classical 3beta-HSD deficiency and also provide valuable information concerning the structure-function relationships of the 3beta-HSD superfamily. Furthermore, several recent studies using type I and type II purified enzymes have elegantly further characterized structure-function relationships responsible for kinetic differences and coenzyme specificity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Classically, patients manifest early in the neonatal period with severe salt-wasting adrenal insufficiency, but broad phenotypic variation is reported (54).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [54]
In the citing paper
“HPA axis activation drives precursor accumulation, in particular 17OHPreg (54).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [54]
Citations
Cites
Items 601–613 of 613
HAN, X., Berdusco, E. T. M., LU, F., & Challis, J. R. G. (1997) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.1997.tb05080.x · Cited by 3
Oh, S., Oh, J. M., Kim, J. J., Choi, M. K., Park, S., Park, O. K., & Chung, Y. T. (1998) · Archivum histologicum japonicum · doi:10.1679/aohc.61.297 · Cited by 3
Murono, E. P., & Washburn, A. L. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90222-j · Cited by 3
MORPHOLOGY OF THE HUMAN ADRENARCHE
Dhom, G. (1973) · European Journal of Endocrinology · doi:10.1530/acta.0.072s027 · Cited by 3
HASEGAWA, T., ISHIDA, M., Harigaya, T., Ishida, N., & MUKOYAMA, H. (1998) · Journal of Equine Science · doi:10.1294/jes.9.45 · Cited by 3
Li, X.-M., Juorio, A. V., Chedrese, P. J., & Murphy, B. D. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90236-q · Cited by 3
Filling, C., Marschall, H., Prozorovski, T., Nordling, E., Persson, B., JÖRNVALL, H., & Oppermann, U. C. T. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4735-8_48 · Cited by 2
Labrie, F., Simard, J., Luu-The, V., & Pelletier, G. (1994) · Springer eBooks · doi:10.1007/978-1-4612-2638-3_7 · Cited by 2
Self-citationThe Effects of GnRH Agonist on Steroidogenesis in the Rat Ovary
Yago, N. (1994) · Folia Endocrinologica Japonica · doi:10.1507/endocrine1927.70.6_543 · Cited by 2
[The effect of progesterone and RU486 on progesterone production in the ovulatory process of rats].
Iwamasa, J. (1991) · PubMed · Cited by 2
Inhibition of 3β-hydroxysteroid-dehydrogenase: An approach for prostate cancer treatment?
Geldof, A. A., Dijkstra, I., Newling, D., & Rao, B. R. (1995) · Pure Amsterdam UMC · Cited by 2
[Human folliculogenesis and local regulation].
Fukaya, T. (1995) · PubMed · Cited by 1
Research works printed but not linked: 22
- Labrie, 1996, DHEA and sex steroids: intracrinology in target tissues. J Endocrinol, 150, S1
- Labrie, 1999, Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues., 69
- Chieffi, 1965, [Histochemical distribution of 3-β-, 17-α- and 17-β-hydroxysteroid dehydrogenase in the human ovary during the menstrual cycle]., Arch Ostet Ginecol, 70, 492
- Tapia Freses, 1965, [Histochemical study of the effect of progesterone on the activity of the enzyme, Δ5, 3β-hydroxysteroid dehydrogenase]., Rev Iber Endocrinol, 12, 393
- Luu-The, 1988, Purification and characterization of human placental 3β-hydroxysteroid dehydrogenase/5–4-isomerase, Clin Invest Med, 11, C32
- Luu-The, 1992, Human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase: characterization of three additional related genes, 426
- Turgeon, 1995, Characterization of the unique cofactor specificity of liver-specific rat 3β-hydroxysteroid dehydrogenase by site-directed mutagenesis, 619
- Grumbach, 1999, Disorders of sex differentitiation., 1303
- Dickson, 1996, Autocrine and paracrine growth factors in the normal and neoplastic breast., 272
- Donohoue, 1995, Congenital adrenal hyperplasia., 2929
- Simard, 2002, Molecular genetics of 17β-hydroxysteroid dehydrogenase and 5α-reductase deficiencies., 297
- de Peretti, 1980, Endocrine studies in two children with male pseudohermaphroditism due to 3β-hydroxysteroid dehydrogenase (3β-HSD) defect., 141
- Gendrel, 1979, [Congenital adrenal hyperplasia due to blockade of 3β-hydroxysteroid dehydrogenase]., Arch Fr Pediatr, 36, 647
- Forest, 1995, Diagnosis of partial 3β-hydroxysteroid dehydrogenase (3β-HSD) questioned: lessons from long-term study and molecular biology., Horm Res, 44, 55
- Simard, 2002, 3β-Hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase deficiency., 209
- Chang, 1993, Molecular basis of the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in patients with mild nonclassic (late-onset) 3β-HSD deficiency congenital adrenal hyperplasia (CAH), 396
- Swofford, 1990, Phylogeny reconstruction., 411
- Yoshimoto, 1988, Case of salt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency: The first Japanese patient., Acta Paediatr Jpn, 92, 1964
- Fisher, 1988, Two brothers with congenital adrenal hyperplasia due to partial 3β-hydroxysteroid dehydrogenase deficiency, Ann Clin Biochem, 25, 133
- Lafont, 1984, Le déficit en 3β-ol-déshydrogénase chez l‘enfant
- Reiter, 2000, Diagnostic criteria for the diagnosis of 3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency: lessons from hormonal and molecular studies in 2 girls presenting with premature pubarche, Horm Res, 53, 76
- Van Seters, 1989, Biochemical concealment of 3βHSD deficiency by long-term steroid substitution, J Steroid Biochem, 36, 174
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals
Sanderson, J. T. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl051 · Cited by 517
“3b-HSD is widely distributed in steroidogenic and nonsteroidogenic tissues and consists of two isoenzymes, which are regulated in a tissue-specific manner (Gingras et al., 2001; Leers-Sucheta et al., 1997; Mason et al., 1997; Simard et al., 2005).”
BackgroundMechanisms of resistance in castration-resistant prostate cancer (CRPC).
Chandrasekar, T., Yang, J. C., Gao, A. C., & Evans, C. P. (2015) · PubMed · doi:10.3978/j.issn.2223-4683.2015.05.02 · Cited by 514
Metadata
- Authors
- Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H.
- Affiliations
- Université Laval (CA)
- Canada Research Chair in Oncogenetics (J.S., M.-L.R., S.G., P.S.), Oncology and Molecular Endocrinology Research Center, Laval University Medical Center, and Laval University, Quebec, Canada G1V 4G2
- Vanderbilt University (US)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-01-04
- Volume
- 26
- Issue
- 4
- Pages
- 525-582
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2107991694
- Cited by
- 620
- References
- 626
- Citations by year
- 2026: 40 · 2025: 32 · 2024: 33 · 2023: 38 · 2022: 32 · 2021: 26 · 2020: 9 · 2019: 31 · 2018: 27 · 2017: 27 · 2016: 27 · 2015: 34 · 2014: 39 · 2013: 30 · 2012: 40
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 3β-hydroxysteroid dehydrogenase, HSD3B1, HSD3B2, gene family evolution, congenital adrenal hyperplasia, steroidogenic factor 1, DAX-1, STAT5, STAT6, epidermal growth factor, IL-4, IL-13, transcriptional regulation
- MeSH terms
- Adrenal Glands, Amino Acid Sequence, Animals, Base Sequence, Female, Gonads, Humans, Isoenzymes, Male, Molecular Sequence Data, Multienzyme Complexes, Organ Specificity, Phylogeny, Placenta, Pregnancy, Progesterone Reductase, Promoter Regions, Genetic, Species Specificity, Steroid Isomerases, Structure-Activity Relationship, Gene Expression Regulation, Enzymologic, Evolution, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.